Home/Filings/4/0001181431-14-013708
4//SEC Filing

INVIVO THERAPEUTICS HOLDINGS CORP. 4

Accession 0001181431-14-013708

CIK 0001292519operating

Filed

Mar 20, 8:00 PM ET

Accepted

Mar 21, 5:47 PM ET

Size

9.6 KB

Accession

0001181431-14-013708

Insider Transaction Report

Form 4
Period: 2014-03-18
REYNOLDS FRANCIS
DirectorCEO, CFO10% Owner
Transactions
  • Sale

    Common Stock

    2014-03-18$2.29/sh12,500$28,6259,648,920 total
  • Sale

    Common Stock

    2014-03-19$2.19/sh12,500$27,3759,636,420 total
  • Sale

    Common Stock

    2014-03-20$2.01/sh12,500$25,1259,623,920 total
  • Sale

    Common Stock

    2014-03-21$1.95/sh2,100$4,0959,621,820 total
Holdings
  • Common Stock

    (indirect: By 401(k))
    23,488
Footnotes (4)
  • [F1]All sales between $2.24 - $2.35.
  • [F2]All sales between $2.10 - $2.25.
  • [F3]All sales between $1.92 - $2.06.
  • [F4]All sales between $1.83 - $2.00.

Issuer

INVIVO THERAPEUTICS HOLDINGS CORP.

CIK 0001292519

Entity typeoperating
IncorporatedNV

Related Parties

1
  • filerCIK 0001292519

Filing Metadata

Form type
4
Filed
Mar 20, 8:00 PM ET
Accepted
Mar 21, 5:47 PM ET
Size
9.6 KB